Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
semaglutide
Fierce Pharma
FDA unleashes warning letters to firms selling compounded GLP-1s
In the letters sent to 30 telehealth companies that market compounded GLP-1 drugs, the agency threatened "legal action without further notice."
Zoey Becker
Mar 4, 2026 8:30am
Fierce Pharma
Hims quits on obesity pill after legal, regulatory heat
Feb 9, 2026 10:24am
Fierce Pharma
FDA commissioner pledges crackdown on compounding practices
Feb 6, 2026 9:59am
Hims & Hers plans to launch $49 copy of Wegovy pill
Feb 5, 2026 1:00pm
Fierce Pharma
Lilly, Novo reach GLP-1 pricing deals with White House
Nov 6, 2025 12:26pm
Hims & Hers in talks with Novo Nordisk to sell obesity pill
Nov 3, 2025 6:30pm